Blake Byers is the founder of NewLimit. NewLimit has raised $682M in total funding. Latest round: Series C. Based in San Francisco, CA.
Blake Byers is a co-founder of NewLimit, a longevity biotech company focused on epigenetic reprogramming to extend human healthspan. He is also the founder of Byers Capital and was previously a partner at Google Ventures (GV). Byers has committed $110 million personally to NewLimit.
Full founder directory · Investor directory · Company funding database · Fundraising library